Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N Duru, Marlies C. van der Goes, J. W. G. Jacobs, et al.
Annals of the Rheumatic Diseases (2013) Vol. 72, Iss. 12, pp. 1905-1913
Open Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Annals of the Rheumatic Diseases (2017) Vol. 76, Iss. 6, pp. 960-977
Open Access | Times Cited: 5201
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 685-699
Open Access | Times Cited: 2314
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Rabia Agca, S.C. Heslinga, Silvia Rollefstad, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 1, pp. 17-28
Open Access | Times Cited: 1147
Avacopan for the Treatment of ANCA-Associated Vasculitis
David Jayne, Peter A. Merkel, Thomas J. Schall, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 7, pp. 599-609
Open Access | Times Cited: 688
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Sofía Ramiro, C. Gaujoux-Viala, J. Nam, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 3, pp. 529-535
Closed Access | Times Cited: 678
A General Introduction to Glucocorticoid Biology
Steven Timmermans, Jolien Souffriau, Claude Libert
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 488
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
Manuel Ramos‐Casals, Pilar Brito‐Zerón, Stefano Bombardieri, et al.
Annals of the Rheumatic Diseases (2019) Vol. 79, Iss. 1, pp. 3-18
Open Access | Times Cited: 462
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
Raashid Luqmani, Ellen Lee, Surjeet Singh, et al.
Health Technology Assessment (2016) Vol. 20, Iss. 90, pp. 1-238
Open Access | Times Cited: 406
Infection Risk and Safety of Corticosteroid Use
Jameel Youssef, Shannon Novosad, Kevin Winthrop
Rheumatic Disease Clinics of North America (2015) Vol. 42, Iss. 1, pp. 157-176
Open Access | Times Cited: 398
A systematic review of intervention thresholds based on FRAX
John А. Kanis, Nicholas C. Harvey, Cyrus Cooper, et al.
Archives of Osteoporosis (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 367
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Bernhard Hellmich, Beatriz Sánchez‐Álamo, Jan Henrik Schirmer, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 30-47
Open Access | Times Cited: 319
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl, J. W. J. Bijlsma, Maarten de Wit, et al.
Annals of the Rheumatic Diseases (2016) Vol. 75, Iss. 6, pp. 952-957
Open Access | Times Cited: 295
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Arthritis & Rheumatology (2015) Vol. 67, Iss. 10, pp. 2569-2580
Open Access | Times Cited: 271
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Christian Dejaco, Yogesh Preet Singh, Pablo Perel, et al.
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 10, pp. 1799-1807
Open Access | Times Cited: 267
Recommendations for the management of autoinflammatory diseases
Nienke M. ter Haar, Marlen Oswald, Jerold Jeyaratnam, et al.
Annals of the Rheumatic Diseases (2015) Vol. 74, Iss. 9, pp. 1636-1644
Open Access | Times Cited: 262
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
Robert Landewé, Pedro Machado, Féline P B Kroon, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 7, pp. 851-858
Open Access | Times Cited: 252
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 760-770
Open Access | Times Cited: 227
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative
Athan Baillet, Laure Gossec, Loreto Carmona, et al.
Annals of the Rheumatic Diseases (2016) Vol. 75, Iss. 6, pp. 965-973
Closed Access | Times Cited: 217
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
Nicholas C. Harvey, E. V. McCloskey, Paul Mitchell, et al.
Osteoporosis International (2017) Vol. 28, Iss. 5, pp. 1507-1529
Open Access | Times Cited: 198
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
Sarah Mackie, Christian Dejaco, Simone Appenzeller, et al.
Lara D. Veeken (2020) Vol. 59, Iss. 3, pp. e1-e23
Open Access | Times Cited: 182
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
Robert Landewé, Féline P B Kroon, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1628-1639
Open Access | Times Cited: 141
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Riccardo Pofi, Giorgio Caratti, David Ray, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 975-1011
Closed Access | Times Cited: 69
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
C. Gaujoux-Viala, J. Nam, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 3, pp. 510-515
Open Access | Times Cited: 157
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
L. Fardet, Irene Petersen, Irwin Nazareth
PLoS Medicine (2016) Vol. 13, Iss. 5, pp. e1002024-e1002024
Open Access | Times Cited: 141
S2e-Leitlinie: Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten
Christoph Fiehn, Johannes Holle, Christof Iking‐Konert, et al.
Zeitschrift für Rheumatologie (2018) Vol. 77, Iss. S2, pp. 35-53
Open Access | Times Cited: 135
Page 1 - Next Page

Scroll to top